Literature DB >> 23952529

Screening for dementia--is it a no brainer?

C Fox1, L Lafortune, M Boustani, T Dening, G Rait, C Brayne.   

Abstract

As people are living longer, dementia is becoming a significant issue for society. Dementia is now recognised as a major concern in society, and the numbers of people estimated to have dementia in the UK population appear to have stabilised at around 700,000 . Globally, 35.6 million people are estimated to meet criteria for dementia, a number predicted to double every 20 years . Given the absence of treatments that significantly alter the natural history of the clinical syndrome of dementia, there has been increased emphasis on early diagnosis, with research exploring assessment tools and biomarkers that might predict with certainty a particular clinical outcome. At the same time, there has been pressure to focus on biomedical profiles, which assume a very close link between the pathobiology and the manifest clinical syndrome.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23952529     DOI: 10.1111/ijcp.12239

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  10 in total

1.  Dementia: Mild cognitive impairment--not always what it seems.

Authors:  Edo Richard; Carol Brayne
Journal:  Nat Rev Neurol       Date:  2014-02-18       Impact factor: 42.937

2.  Who has undiagnosed dementia? A cross-sectional analysis of participants of the Aging, Demographics and Memory Study.

Authors:  George M Savva; Antony Arthur
Journal:  Age Ageing       Date:  2015-03-10       Impact factor: 10.668

3.  In patients suspected of cognitive decline, what is the most accurate in-office screening instrument to determine if there is dementia needing further evaluation and management?

Authors:  Jamie Quitoriano; Robert M Hamm
Journal:  J Okla State Med Assoc       Date:  2017 Sep-Oct

Review 4.  Multimodality imaging of Alzheimer disease and other neurodegenerative dementias.

Authors:  Ilya M Nasrallah; David A Wolk
Journal:  J Nucl Med       Date:  2014-11-20       Impact factor: 10.057

5.  Characteristics of people living with undiagnosed dementia: findings from the CFAS Wales study.

Authors:  Laura D Gamble; Fiona E Matthews; Ian R Jones; Alex E Hillman; Bob Woods; Catherine A Macleod; Anthony Martyr; Rachel Collins; Claire Pentecost; Jennifer M Rusted; Linda Clare
Journal:  BMC Geriatr       Date:  2022-05-10       Impact factor: 4.070

6.  Are We There Yet? Exploring the Impact of Translating Cognitive Tests for Dementia Using Mobile Technology in an Aging Population.

Authors:  Kai Ruggeri; Áine Maguire; Jack L Andrews; Eric Martin; Shantanu Menon
Journal:  Front Aging Neurosci       Date:  2016-03-17       Impact factor: 5.750

7.  Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.

Authors:  Lea M Gerischer; Andreas Fehlner; Theresa Köbe; Kristin Prehn; Daria Antonenko; Ulrike Grittner; Jürgen Braun; Ingolf Sack; Agnes Flöel
Journal:  Neuroimage Clin       Date:  2017-12-20       Impact factor: 4.881

8.  Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data.

Authors:  K Walters; S Hardoon; I Petersen; S Iliffe; R Z Omar; I Nazareth; G Rait
Journal:  BMC Med       Date:  2016-01-21       Impact factor: 8.775

9.  Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.

Authors:  Richard Milne; Eline Bunnik; Ana Diaz; Edo Richard; Shirlene Badger; Dianne Gove; Jean Georges; Karine Fauria; Jose-Luis Molinuevo; Katie Wells; Craig Ritchie; Carol Brayne
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

10.  Dementia case-finding in hospitals: a qualitative study exploring the views of healthcare professionals in English primary care and secondary care.

Authors:  Anne-Marie Burn; Jane Fleming; Carol Brayne; Chris Fox; Frances Bunn
Journal:  BMJ Open       Date:  2018-03-17       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.